Results 11 to 20 of about 11,328 (118)

Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End‐Organ Damage Among Adults With Arterial Hypertension

open access: yesThe Journal of Clinical Hypertension
Arterial hypertension often coexists with comorbidities that increase vascular damage. Although the primary goal is to reduce cardiovascular risk, the available risk scores can produce varying estimates.
Silvia Palomo‐Piñón   +12 more
doaj   +2 more sources

The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3. [PDF]

open access: yesPulm Circ
ABSTRACT In this first global study of patient perspectives in Group 2 and 3 PH, we demonstrate that those with Group 3 PH report significantly greater adverse impacts on physical and mental wellbeing than those in Group 2 or Group 1, despite a lower treatment side‐effect profile.
Bunclark K   +17 more
europepmc   +2 more sources

Pulmonary Hypertension Global Patient Survey: A Call to Action 2025. [PDF]

open access: yesPulm Circ
Pulmonary Circulation, Volume 15, Issue 3, July 2025.
Newman J   +18 more
europepmc   +2 more sources

Reproducibilidad y confiabilidad de un protocolo de 4 días de monitoreo domiciliario de presión arterial con y sin exclusión del primer día

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba, 2018
Las guías de Monitoreo Domiciliario de Presión Arterial (MDPA) recomiendan la exclusión del primer día, utilizando mediciones matutinas y vespertinas. El objetivo de este trabajo fue determinar la reproducibilidad y confiabilidad de un protocolo de MDPA ...
Jessica Barochiner   +9 more
doaj   +1 more source

Nueva evidencia en el tratamiento de la enfermedad renal diabética: ¿qué aporta la finerenona?

open access: yesRevista Colombiana de Nefrología, 2022
Contexto: la enfermedad renal diabética (ERD) es la primera causa a nivel mundial de enfermedad renal crónica (ERC) e impacta directamente en el riesgo cardiovascular y mortalidad de los pacientes con diabetes mellitus (DM). La finerenona, un antagonista
Jorge Rico Fontalvo   +9 more
doaj   +1 more source

Análisis de los factores que determinan la adherencia terapéutica del paciente hipertenso

open access: yesEnfermería Nefrológica, 2014
Introducción: La baja adherencia al tratamiento en enfermedades crónicas como la hipertensión arterial, sigue siendo actualmente un problema latente en nuestro país.
Inmaculada Zurera Delgado   +2 more
doaj   +1 more source

P55 Factors associated with glycemic goal achievement in Type 2 Diabetes

open access: yesRevista de la Sociedad Argentina de Diabetes, 2020
Introduction: Glycemic goal achievement is a matter of great health impact. Adequate glycemic control prevents and decreases diabetes chronic complications and prolongs survival.
Silvana Alejandra Milrad   +7 more
doaj   +1 more source

O15 Insulin therapy in type 2 diabetes. how do specialists insulinize?

open access: yesRevista de la Sociedad Argentina de Diabetes, 2020
Introduction: Insulin therapy is an effective tool to achieve the glycemic goal (A1c). The percentage of people with T2D treated with insulin and the regimens used vary by country.
Solange Houssay   +7 more
doaj   +1 more source

Phosphorus and Nutrition in Chronic Kidney Disease

open access: yesInternational Journal of Nephrology, 2012
Patients with renal impairment progressively lose the ability to excrete phosphorus. Decreased glomerular filtration of phosphorus is initially compensated by decreased tubular reabsorption, regulated by PTH and FGF23, maintaining normal serum ...
Emilio González-Parra   +3 more
doaj   +1 more source

First‐trimester prediction and prevention of preterm pre‐eclampsia in women with chronic hypertension

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 5, Page 613-622, May 2026.
ABSTRACT Objectives To evaluate the effect of aspirin on gestational age at delivery due to preterm pre‐eclampsia (PE) in women with chronic hypertension (CH), to assess the predictive performance of the Fetal Medicine Foundation (FMF) first‐trimester competing‐risks model for preterm PE in this high‐risk group and to evaluate how parity, previous PE ...
D. L. Rolnik   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy